41 research outputs found
Psychosocial Treatment of Children in Foster Care: A Review
A substantial number of children in foster care exhibit psychiatric difficulties. Recent epidemiologi-cal and historical trends in foster care, clinical findings about the adjustment of children in foster care, and adult outcomes are reviewed, followed by a description of current approaches to treatment and extant empirical support. Available interventions for these children can be categorized as either symptom-focused or systemic, with empirical support for specific methods ranging from scant to substantial. Even with treatment, behavioral and emotional problems often persist into adulthood, resulting in poor functional outcomes. We suggest that self-regulation may be an important mediat-ing factor in the appearance of emotional and behavioral disturbance in these children
Nations within a nation: variations in epidemiological transition across the states of India, 1990â2016 in the Global Burden of Disease Study
18% of the world's population lives in India, and many states of India have populations similar to those of large countries. Action to effectively improve population health in India requires availability of reliable and comprehensive state-level estimates of disease burden and risk factors over time. Such comprehensive estimates have not been available so far for all major diseases and risk factors. Thus, we aimed to estimate the disease burden and risk factors in every state of India as part of the Global Burden of Disease (GBD) Study 2016
Recommended from our members
Complement C1q subcomponent subunit A
Complement C1q subcomponent subunit A (C1qA) is one of the three components of C1q molecule. Functional C1q is composed of eighteen polypeptide chains: six C1qA chains, six C1qB chains, and six C1qC chains, which are arranged as six heterotrimers of ABC: (ABC)6. Each of the individual C1q polypeptide chain consists of a N-terminal region and a C-terminal globular region (gC1q), of ~135 residues. Each N-terminal consists of 2-11 amino acid segments containing a half-cysteine residue that is involved in formation of inter-chain disulphide bonds, followed by a collagen-like region (CLR) consisting of ~81 residues. The collagen-like regions in A, B and C chains of each heterotrimer come together to form a triple helical collagen like structure. Further, A and B chains in each heterotrimer are bound by a disulphide bond, while C chain forms a disulphide bond with a C chain from the adjoining heterotrimer. Therefore the eighteen subunits come together to form six globular heads (gC1q), which are clusters of 3 independently folded C-terminal domains of the A, B and C chain. These globular domains recognize an array of self, non-self and altered-self ligands. C1q associates with the proenzymes C1r and C1s (2 molecules of each, in the molar ratio of 1:2:2 in a calcium dependent manner) to yield an active C1 complex, the first component of the serum complement system. C1r, upon binding of gC1q to an inciting stimulus, autoactivates itself and catalyzes breakage of a C1s ester bond, resulting in C1s activation and subsequent cleavage of C2 and C4 into their respective âaâ and âbâ fragments. Recognition of ligands by C1q molecule also defines C1q as a pattern recognition molecule (PRM). C1q recognizes distinct structures either directly on microbial structures and apoptotic cells, or indirectly after their recognition by antibodies or C-reactive protein (CRP). C1q in turn binds to multiple receptors (such as cC1qR (calreticulin), integrin α2ÎČ1 or other molecules on the surface of specific cell types of either myeloid or endothelial cell orgin) and shows regulated broad physiological functions beyond complement activation
Recommended from our members
Complement C1q subcomponent subunit A
Complement C1q subcomponent subunit A (C1qA) is one of the three components of C1q molecule. Functional C1q is composed of eighteen polypeptide chains: six C1qA chains, six C1qB chains, and six C1qC chains, which are arranged as six heterotrimers of ABC: (ABC)6. Each of the individual C1q polypeptide chain consists of a N-terminal region and a C-terminal globular region (gC1q), of ~135 residues. Each N-terminal consists of 2-11 amino acid segments containing a half-cysteine residue that is involved in formation of inter-chain disulphide bonds, followed by a collagen-like region (CLR) consisting of ~81 residues. The collagen-like regions in A, B and C chains of each heterotrimer come together to form a triple helical collagen like structure. Further, A and B chains in each heterotrimer are bound by a disulphide bond, while C chain forms a disulphide bond with a C chain from the adjoining heterotrimer. Therefore the eighteen subunits come together to form six globular heads (gC1q), which are clusters of 3 independently folded C-terminal domains of the A, B and C chain. These globular domains recognize an array of self, non-self and altered-self ligands. C1q associates with the proenzymes C1r and C1s (2 molecules of each, in the molar ratio of 1:2:2 in a calcium dependent manner) to yield an active C1 complex, the first component of the serum complement system. C1r, upon binding of gC1q to an inciting stimulus, autoactivates itself and catalyzes breakage of a C1s ester bond, resulting in C1s activation and subsequent cleavage of C2 and C4 into their respective âaâ and âbâ fragments. Recognition of ligands by C1q molecule also defines C1q as a pattern recognition molecule (PRM). C1q recognizes distinct structures either directly on microbial structures and apoptotic cells, or indirectly after their recognition by antibodies or C-reactive protein (CRP). C1q in turn binds to multiple receptors (such as cC1qR (calreticulin), integrin α2ÎČ1 or other molecules on the surface of specific cell types of either myeloid or endothelial cell orgin) and shows regulated broad physiological functions beyond complement activation
Effect of dietary intervention, with or without cointerventions, on inflammatory markers in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis
Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of disease from simple steatosis to nonalcoholic steatohepatitis, with inflammatory cytokines and adipokines identified as drivers of disease progression. Poor dietary patterns are known to promote an inflammatory milieu, although the effects of specific diets remain largely unknown. This review aimed to gather and summarize new and existing evidence on the effect of dietary intervention on inflammatory markers in patients with NAFLD. The electronic databases MEDLINE, EMBASE, CINAHL, and Cochrane were searched for clinical trials which investigated outcomes of inflammatory cytokines and adipokines. Eligible studies included adults >18 y with NAFLD, which compared a dietary intervention with an alternative diet or control (no intervention) group or were accompanied by supplementation or other lifestyle interventions. Outcomes for inflammatory markers were grouped and pooled for meta-analysis where heterogeneity was allowed. Methodological quality and risk of bias were assessed using the Academy of Nutrition and Dietetics Criteria. Overall, 44 studies with a total of 2579 participants were included. Meta-analyses indicated intervention with an isocaloric diet plus supplement was more effective in reducing C-reactive protein (CRP) [standard mean difference (SMD): 0.44; 95% CI: 0.20, 0.68; P = 0.0003] and tumor necrosis factor-alpha (TNF-α) (SMD: 0.74; 95% CI: 0.02, 1.46; P = 0.03) than an isocaloric diet alone. No significant weighting was shown between a hypocaloric diet with or without supplementation for CRP (SMD: 0.30; 95% CI: â0.84, 1.44; P = 0.60) and TNF-α (SMD: 0.01; 95% CI: â0.43, 0.45; P = 0.97). In conclusion, hypocaloric and energy-restricted diets alone or with supplementation, and isocaloric diets with supplementation were shown to be most effective in improving the inflammatory profile of patients with NAFLD. To better determine the effectiveness of dietary intervention alone on a NAFLD population, further investigations of longer durations, with larger sample sizes are required.</p
Non alcoholic fatty liver disease patients attending two metropolitan hospitals in Melbourne, Australia; high risk status and low prevalence
Background: Nonâ alcoholic fatty liver disease (NAFLD) is the commonest liver disease
globally with increased rates in high risk populations including type 2 diabetes and obesity.
The condition increases the risk of end stage liver disease, hepatocellular carcinoma and allcause
mortality. NAFLD is asymptomatic and often remains undiagnosed as routine
screening in high risk groups is not practised.
Aims: The aim of this study was to determine the rates and characteristics of NAFLD
patients attending liver clinics at two Melbourne metropolitan hospitals.
Methods: Liver clinics were prospectively screened for ten consecutive months and
participants with a diagnosis of NAFLD were further evaluated using pathology and imaging
results obtained from medical records.
Results: Of the 2050 patients screened, 148 (7%) had NAFLD predominantly diagnosed using
ultrasound (81%). NAFLD patients were obese (mean BMI 30.7 ± 5.9kg/m2), insulin resistant
(median HOMA 4.2 (3.2) mmol/L), had elevated liver enzymes (ALT median, males 47.0
(34.3), females 36.0 (28.0) U/L) and 18% of patients with liver stiffness measure >12kPa
suggesting a moderate probability of cirrhosis. Patients with liver stiffness measure â„9.6kPa
had significantly higher: glucose (median 5.5 (1.2) vs. 6.2 (5.3) mmol/L, p=0.007), AST levels
(median 25.5 (26.0) vs. 41.0 (62.0) u/L, p=0.0005) and HOMA (3.1 (3.0) vs. 5.4 (5.5) mmol/L,
p= 0.040).
Conclusions: NAFLD constituted a minority of liver clinic patients, most were obese, insulin
resistant, hypertensive and many had an elevated liver stiffness measurement. NAFLD poses
added adverse health outcomes to high risk patients and therefore early detection is
warranted
A Mediterranean and lowâfat dietary intervention in nonâalcoholic fatty liver disease patients: Exploring participant experience and perceptions about dietary change
Background: A Mediterranean diet (MD) appears to be beneficial in nonâ alcoholic fatty liver disease (NAFLD) patients in Mediterranean countries; however, the acceptability of a MD in nonâMediterranean populations has not been thoroughly explored. The present study aimed to explore the acceptability through understanding the barriers and enablers of the MD and lowâfat diet (LFD) interventions as perceived by participating Australian adults from multicultural backgrounds with NAFLD.Â
Methods: Semiâstructured telephone interviews were performed with 23 NAFLD trial participants at the end of a 12âweek dietary intervention in a multicentre, parallel, randomised clinical trial. Data were analysed using thematic analysis.Â
Results: Participants reported that they enjoyed taking part in the MD and LFD interventions and perceived that they had positive health benefits from their participation. Compared with the LFD, the MD group placed greater emphasis on enjoyment and intention to maintain dietary changes. Novelty, convenience and the ability to swap food/meals were key enablers for the successful implementation for both of the dietary interventions. Flavour and enjoyment of food, expressed more prominently by MD intervention participants, were fundamental components of the diets with regard to reported adherence and intention to maintain dietary change.
Conclusions: Participants randomised to the MD reported greater acceptability of the diet than those randomised to the LFD, predominantly related to perceived novelty and palatability of the diet.Â
</p
The effect of high-polyphenol extra virgin olive oil on cardiovascular risk factors: a systematic review and meta-analysis
The polyphenol fraction of extra-virgin olive oil may be partly responsible for its cardioprotective effects. The aim of this systematic review and meta-analysis was to evaluate the effect of high versus low polyphenol olive oil on cardiovascular disease (CVD) risk factors in clinical trials. In accordance with PRISMA guidelines, CINAHL, PubMed, Embase and Cochrane databases were systematically searched for relevant studies. Randomized controlled trials that investigated markers of CVD risk (e.g. outcomes related to cholesterol, inflammation, oxidative stress) were included. Risk of bias was assessed using the Jadad scale. A meta-analysis was conducted using clinical trial data with available CVD risk outcomes. Twenty-six studies were included. Compared to low polyphenol olive oil, high polyphenol olive oil significantly improved measures of malondialdehyde (MD: -0.07”mol/L [95%CI: -0.12, -0.02”mol/L]; I: 88%; pâ=â0.004), oxidized LDL (SMD: -0.44 [95%CI: -0.78, -0.10”mol/L]; I: 41%; Pâ=â0.01), total cholesterol (MD 4.5\ua0mg/dL [95%CI: -6.54, -2.39\ua0mg/dL];